(JHG) Janus Henderson - Overview
Exchange: NYSE •
Country: United Kingdom •
Currency: USD •
Type: Common Stock •
ISIN: JE00BYPZJM29
Stock:
Total Rating 53
Risk 71
Buy Signal 1.45
| Risk 5d forecast | |
|---|---|
| Volatility | 20.4% |
| Relative Tail Risk | -9.38% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.67 |
| Alpha | 1.31 |
| Character TTM | |
|---|---|
| Beta | 1.267 |
| Beta Downside | 1.943 |
| Drawdowns 3y | |
|---|---|
| Max DD | 35.29% |
| CAGR/Max DD | 0.79 |
EPS (Earnings per Share)
Revenue
Description: JHG Janus Henderson
Janus Henderson Group plc is an asset management holding entity. Through its subsidiaries, the firm provides services to institutional, retail clients, and high net worth clients. It manages separate client-focused equity and fixed income portfolios. The firm also manages equity, fixed income, and balanced mutual funds for its clients. It specializes in growth capital, middle market & buyout investments. It focuses on commercial services and supplies, air freight & logistics, consumer durables and apparel, hotels, beverage & food product, health care, diversified financial services, multi-sector holdings, specialized finance, consumer finance, capital markets, REITs, mortgage REITs, communication equipment, media, alternative energy resource. It invests in public equity and fixed income markets, as well as invests in real estate and private equity. The firm invests in companies based in China & India. It invest between $10 million and $30 million. Janus Henderson Group plc was founded in 1934 and is based in London, United Kingdom with additional offices in Jersey, United Kingdom and Sydney, Australia.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 1.06b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA -0.97 > 1.0 |
| NWC/Revenue: 45.07% < 20% (prev 77.01%; Δ -31.93% < -1%) |
| CFO/TA 0.04 > 3% & CFO 311.2m > Net Income 1.06b |
| Net Debt (-858.4m) to EBITDA (685.9m): -1.25 < 3 |
| Current Ratio: 69.46 > 1.5 & < 3 |
| Outstanding Shares: last quarter (154.1m) vs 12m ago -0.44% < -2% |
| Gross Margin: 80.23% > 18% (prev 0.69%; Δ 7954 % > 0.5%) |
| Asset Turnover: 46.42% > 50% (prev 35.52%; Δ 10.90% > 0%) |
| Interest Coverage Ratio: 36.82 > 6 (EBITDA TTM 685.9m / Interest Expense TTM 17.9m) |
Altman Z'' 4.15
| A: 0.19 (Total Current Assets 1.62b - Total Current Liabilities 23.3m) / Total Assets 8.29b |
| B: 0.14 (Retained Earnings 1.18b / Total Assets 8.29b) |
| C: 0.09 (EBIT TTM 659.0m / Avg Total Assets 7.63b) |
| D: 1.75 (Book Value of Equity 5.28b / Total Liabilities 3.01b) |
| Altman-Z'' Score: 4.15 = AA |
Beneish M
| DSRI: none (Receivables none/432.7m, Revenue 3.54b/2.47b) |
| GMI: 0.86 (GM 80.23% / 68.69%) |
| AQI: 1.30 (AQ_t 0.80 / AQ_t-1 0.62) |
| SGI: 1.43 (Revenue 3.54b / 2.47b) |
| TATA: 0.09 (NI 1.06b - CFO 311.2m) / TA 8.29b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of JHG shares?
As of February 26, 2026, the stock is trading at USD 50.15 with a total of 2,604,840 shares traded.
Over the past week, the price has changed by +2.31%, over one month by +4.54%, over three months by +17.42% and over the past year by +23.35%.
Over the past week, the price has changed by +2.31%, over one month by +4.54%, over three months by +17.42% and over the past year by +23.35%.
Is JHG a buy, sell or hold?
Janus Henderson has received a consensus analysts rating of 3.45.
Therefor, it is recommend to hold JHG.
- StrongBuy: 2
- Buy: 1
- Hold: 8
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the JHG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 50.1 | -0% |
| Analysts Target Price | 50.1 | -0% |
JHG Fundamental Data Overview February 24, 2026
P/E Trailing = 9.5985
P/E Forward = 11.1732
P/S = 2.4207
P/B = 1.4706
P/EG = 0.9721
Revenue TTM = 3.54b USD
EBIT TTM = 659.0m USD
EBITDA TTM = 685.9m USD
Long Term Debt = 395.5m USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 395.5m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -858.4m USD (from netDebt column, last fiscal year)
Enterprise Value = 6.64b USD (7.50b + Debt 395.5m - CCE 1.25b)
Interest Coverage Ratio = 36.82 (Ebit TTM 659.0m / Interest Expense TTM 17.9m)
EV/FCF = 10.47x (Enterprise Value 6.64b / FCF TTM 634.0m)
FCF Yield = 9.55% (FCF TTM 634.0m / Enterprise Value 6.64b)
FCF Margin = 17.91% (FCF TTM 634.0m / Revenue TTM 3.54b)
Net Margin = 30.01% (Net Income TTM 1.06b / Revenue TTM 3.54b)
Gross Margin = 80.23% ((Revenue TTM 3.54b - Cost of Revenue TTM 699.7m) / Revenue TTM)
Gross Margin QoQ = none% (prev 73.19%)
Tobins Q-Ratio = 0.80 (Enterprise Value 6.64b / Total Assets 8.29b)
Interest Expense / Debt = 1.54% (Interest Expense 6.10m / Debt 395.5m)
Taxrate = 22.10% (120.9m / 547.1m)
NOPAT = 513.4m (EBIT 659.0m * (1 - 22.10%))
Current Ratio = 69.46 (Total Current Assets 1.62b / Total Current Liabilities 23.3m)
Debt / Equity = 0.07 (Debt 395.5m / totalStockholderEquity, last quarter 5.28b)
Debt / EBITDA = -1.25 (Net Debt -858.4m / EBITDA 685.9m)
Debt / FCF = -1.35 (Net Debt -858.4m / FCF TTM 634.0m)
Total Stockholder Equity = 5.00b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.93% (Net Income 1.06b / Total Assets 8.29b)
RoE = 21.22% (Net Income TTM 1.06b / Total Stockholder Equity 5.00b)
RoCE = 12.21% (EBIT 659.0m / Capital Employed (Equity 5.00b + L.T.Debt 395.5m))
RoIC = 9.98% (NOPAT 513.4m / Invested Capital 5.14b)
WACC = 10.11% (E(7.50b)/V(7.89b) * Re(10.58%) + D(395.5m)/V(7.89b) * Rd(1.54%) * (1-Tc(0.22)))
Discount Rate = 10.58% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.92%
[DCF] Terminal Value 71.44% ; FCFF base≈620.4m ; Y1≈644.3m ; Y5≈735.7m
[DCF] Fair Price = 66.55 (EV 9.08b - Net Debt -858.4m = Equity 9.94b / Shares 149.4m; r=10.11% [WACC]; 5y FCF grow 4.04% → 2.90% )
EPS Correlation: 78.20 | EPS CAGR: 30.07% | SUE: 4.0 | # QB: 7
Revenue Correlation: 72.35 | Revenue CAGR: 17.70% | SUE: 2.13 | # QB: 3
EPS next Quarter (2026-03-31): EPS=1.01 | Chg7d=+0.048 | Chg30d=+0.050 | Revisions Net=-1 | Analysts=2
EPS current Year (2026-12-31): EPS=4.51 | Chg7d=+0.140 | Chg30d=+0.130 | Revisions Net=+2 | Growth EPS=-5.7% | Growth Revenue=-3.0%
EPS next Year (2027-12-31): EPS=4.84 | Chg7d=+0.086 | Chg30d=+0.079 | Revisions Net=+3 | Growth EPS=+7.4% | Growth Revenue=+5.3%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.2% (Discount Rate 10.6% - Earnings Yield 10.4%)
[Growth] Growth Spread = +14.5% (Analyst 14.7% - Implied 0.2%)
P/E Forward = 11.1732
P/S = 2.4207
P/B = 1.4706
P/EG = 0.9721
Revenue TTM = 3.54b USD
EBIT TTM = 659.0m USD
EBITDA TTM = 685.9m USD
Long Term Debt = 395.5m USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 395.5m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -858.4m USD (from netDebt column, last fiscal year)
Enterprise Value = 6.64b USD (7.50b + Debt 395.5m - CCE 1.25b)
Interest Coverage Ratio = 36.82 (Ebit TTM 659.0m / Interest Expense TTM 17.9m)
EV/FCF = 10.47x (Enterprise Value 6.64b / FCF TTM 634.0m)
FCF Yield = 9.55% (FCF TTM 634.0m / Enterprise Value 6.64b)
FCF Margin = 17.91% (FCF TTM 634.0m / Revenue TTM 3.54b)
Net Margin = 30.01% (Net Income TTM 1.06b / Revenue TTM 3.54b)
Gross Margin = 80.23% ((Revenue TTM 3.54b - Cost of Revenue TTM 699.7m) / Revenue TTM)
Gross Margin QoQ = none% (prev 73.19%)
Tobins Q-Ratio = 0.80 (Enterprise Value 6.64b / Total Assets 8.29b)
Interest Expense / Debt = 1.54% (Interest Expense 6.10m / Debt 395.5m)
Taxrate = 22.10% (120.9m / 547.1m)
NOPAT = 513.4m (EBIT 659.0m * (1 - 22.10%))
Current Ratio = 69.46 (Total Current Assets 1.62b / Total Current Liabilities 23.3m)
Debt / Equity = 0.07 (Debt 395.5m / totalStockholderEquity, last quarter 5.28b)
Debt / EBITDA = -1.25 (Net Debt -858.4m / EBITDA 685.9m)
Debt / FCF = -1.35 (Net Debt -858.4m / FCF TTM 634.0m)
Total Stockholder Equity = 5.00b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.93% (Net Income 1.06b / Total Assets 8.29b)
RoE = 21.22% (Net Income TTM 1.06b / Total Stockholder Equity 5.00b)
RoCE = 12.21% (EBIT 659.0m / Capital Employed (Equity 5.00b + L.T.Debt 395.5m))
RoIC = 9.98% (NOPAT 513.4m / Invested Capital 5.14b)
WACC = 10.11% (E(7.50b)/V(7.89b) * Re(10.58%) + D(395.5m)/V(7.89b) * Rd(1.54%) * (1-Tc(0.22)))
Discount Rate = 10.58% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.92%
[DCF] Terminal Value 71.44% ; FCFF base≈620.4m ; Y1≈644.3m ; Y5≈735.7m
[DCF] Fair Price = 66.55 (EV 9.08b - Net Debt -858.4m = Equity 9.94b / Shares 149.4m; r=10.11% [WACC]; 5y FCF grow 4.04% → 2.90% )
EPS Correlation: 78.20 | EPS CAGR: 30.07% | SUE: 4.0 | # QB: 7
Revenue Correlation: 72.35 | Revenue CAGR: 17.70% | SUE: 2.13 | # QB: 3
EPS next Quarter (2026-03-31): EPS=1.01 | Chg7d=+0.048 | Chg30d=+0.050 | Revisions Net=-1 | Analysts=2
EPS current Year (2026-12-31): EPS=4.51 | Chg7d=+0.140 | Chg30d=+0.130 | Revisions Net=+2 | Growth EPS=-5.7% | Growth Revenue=-3.0%
EPS next Year (2027-12-31): EPS=4.84 | Chg7d=+0.086 | Chg30d=+0.079 | Revisions Net=+3 | Growth EPS=+7.4% | Growth Revenue=+5.3%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.2% (Discount Rate 10.6% - Earnings Yield 10.4%)
[Growth] Growth Spread = +14.5% (Analyst 14.7% - Implied 0.2%)